Back to Top
Brayton Purcell LLP
Call for A Free Consultation
Nationwide Service for over 30 years

December 2004 Archives

Celebrex® and Bextra® Linked to Heart Problems

FDA Recommends Limiting Use of Celebrex® and Bextra® WASHINGTON, DC -- December 30, 2004 -- The arthritis drugs Celebrex® (celecoxib) and Bextra® (valdecoxib) may be linked to an increased risk of heart attacks and strokes, especially when they are used for long periods of time or after heart surgery, the...

FDA Issues Caution About Aleve®

Aleve® May Increase Heart Problems, According to Recent Study WASHINGTON, DC -- December 23, 2004 -- Patients taking the common painkiller naproxen or Aleve®, may have an increased risk of heart problems, according to a study cited by the Food and Drug Administration (FDA). A total of 2,500 seniors took...

US Has Not Yet Joined the WHO Tobacco Treaty

WHO Tobacco Treaty Set to Become Law GENEVA, SWITZERLAND -- December 17, 2004 -- Peru became the 40th country to ratify the World Health Organization Framework Convention on Tobacco Control (the WHO FCTC or Treaty) last month, allowing the document to go into effect as international law on February 28,...

Bextra® Is Related to Vioxx, Which Was Recalled

Bextra® Label Updated to Warn About Heart Problems and Stevens-Johnson Syndrome WASHINGTON, DC -- December 17, 2004 -- Patients who have undergone heart bypass surgery should not take the popular arthritis drug, Bextra®, because it increases their risk of additional heart problems, according to a warning added to the drug's...